Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages
Author:
Funder
Cancéropole Grand Ouest
Ligue Nationale contre le Cancer
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference56 articles.
1. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis;Verstovsek;N. Engl. J. Med.,2010
2. Emerging treatments for classical myeloproliferative neoplasms;Vannucchi;Blood,2017
3. Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis;Mesa;IDrugs,2010
4. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms;Quintas-Cardama;Blood,2010
5. The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms;Bjorn;Clin. Case Rep.,2015
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector;Molecular Therapy - Nucleic Acids;2024-09
2. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells;Frontiers in Immunology;2024-08-12
3. The crucial regulatory role of type I interferon in inflammatory diseases;Cell & Bioscience;2023-12-20
4. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2;Acta Pharmacologica Sinica;2023-10-16
5. IL-13 neutralization attenuates carotid artery intimal hyperplasia and increases endothelial cell migration via modulating the JAK-1/STAT-3 signaling pathway;Cell Adhesion & Migration;2023-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3